Simpler PCa Grading System Proposed

Tumors fall into 1 of 5 grade groups based on what pathologic findings indicate about prognosis.

Belatacept Improves Kidney Transplant Outcomes

Immunosuppression regimens based on belatacept rather than cyclosporine are associated with better 7-year outcomes among kidney transplant recipients.

PCa Patients Unaware of Sexual Complications

Patients who undergo radical prostatectomy (RP) have unrealistic expectations about their sexual function after the operation, new study findings reveal.

Recombinant Erythropoietin Benefits CKD

Treatment with recombinant human erythropoietin (rHuEPO) in patients with chronic kidney disease (CKD) but not on dialysis corrects anemia, reduces the need for blood transfusions, and improves quality of life and exercise capacity, researchers concluded from a systematic review.

Enzalutamide More Effective

Data support the use of enzalutamide instead of bicalutamide in patients with asymptomatic or mildly symptomatic metastatic castration-resistant prostate cancer (mCRPC), researchers concluded.

Earlier ESA May Improve Renal Outcomes

Earlier treatment of anemia with an erythropoiesis-stimulating agent (ESA) may be more effective at decreasing the risk of renal events in patients with chronic kidney disease (CKD) not yet on dialysis.

HIPAA Compliance Solutions for Small Practices

Many small practices fall short on requirements because they do not have the resources to comply.

AKI Diagnostic Testing May Be Excessive

Many diagnostic tests for investigating acute kidney injury (AKI) have limited clinical utility, even when results are positive or abnormal, a new study found.

Flavonoid-Rich Foods May Lower ED

Men who regularly consume foods rich in flavonoids may have a lower risk of erectile dysfunction (ED).

Online Tool Helps Predict ESRD

A new online tool may help predict whether patients with chronic kidney disease will develop kidney failure in the next 2 to 5 years.

Go With the Patient Flow

Appointment schedules should reflect physicians' work style and patient demands.

CME: SGLT-2 Inhibitors for Type 2 ...

Increased clinical research has been focused on the sodium-glucose co-transporter 2 (SGLT-2) inhibitors for the management of type 2 diabetes.

Looking for a Job?

Access our job board to view over 1,000 job openings throughout the US.

RUN Social Media Survey

Tell us about your social media habits for a chance to win a free gift card.

Xtandi Resource Center

Access information and support materials for Xtandi that can help your practice and patients with metastatic castration-resistant prostate cancer.

Online Poll

Sign Up for Free e-newsletters